Clinical Trial Update: Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A long-term safety extension study (VIT45) for treatment of anemia in non-dialysis dependent chronic kidney disease (Phase 3) has completed; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• VIT45

Snippet

Sponsor: American Regent, Inc. | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2015-06-10